Growth Metrics

Nexalin Technology (NXL) Cash & Equivalents Growth (1y) (2022 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.15%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 24.05%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -7.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 100.41%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -22.13%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 20.15%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 23.57%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -7.71%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 156.03%
10 Nexalin Technology 11.19 Mn 8.48 Mn 13,133.00 94.19%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 94.19%
Dec 31, 2025 434.12%
Sep 30, 2025 4,521.17%
Jun 30, 2025 531.66%
Mar 31, 2025 -61.07%
Dec 31, 2024 -75.74%
Sep 30, 2024 -77.47%
Jun 30, 2024 -80.99%
Mar 31, 2024 813.17%
Dec 31, 2023 -65.33%
Sep 30, 2023 -95.40%
Dec 31, 2022 932.25%